Alzheimer's disease (AD) is a brain-related disease in which the condition of the patient gets
worse with time. AD is not a curable disease by any medication. It is impossible to halt the …

Background Alzheimer's disease (AD) is a neurological disorder of unknown cause,
resulting in the death of brain cells. Identifying some of the modifiable risk factors for AD …

Alzheimer's is a neurodegenerative disorder affecting the central nervous system and
cognitive processes, explicitly impairing detailed mental analysis. Throughout this condition …

Alzheimer's disease poses a global health concern with unmet demand requiring creative
approaches to discover new medications. In this study, we investigated the chemical …

Abstract Aggregation of amyloid β 1–42 (Aβ 1–42) peptide within the brain is considered
one of the main causes of the neuropathological changes associated with Alzheimer's …

Accepted: 12 October 2022 Alzheimer's disease (AD) is an irreversible and degenerative
brain condition that gradually damages memory and thinking abilities. Despite being …

All biological tissues and bodily fluids include the autacoid adenosine. The P1 class of
purinergic receptors includes adenosine receptors. Four distinct G-protein-coupled …

Alzheimer's disease (AD) is one of the most progressive and prevalent types of
neurodegenerative diseases in the aging population (aged> 65 years) and is considered a …

Alzheimer's disease (AD) is an obvious neurological disorder characterized by progressive
brain cell death that resulted in memory loss, cognitive decline, and finally dementia …

Background: Diabetes mellitus and Alzheimer's disease are two common diseases that
majorly affect the elderly population. Patients in both cases are increasing day by day. They …